Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Acquisition/DispositionItem 2.01 · 8-KMEDIUM RiskNeutral

CLARIVATE PLC

clarivate.com
Filed: Jul 6, 2026London, VirginiaCIK: 0001764046Information Technology
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Clarivate PLC announced an agreement to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC on July 6, 2026, as part of a strategic restructuring to streamline operations and focus on core business areas.

Key Takeaways

Clarivate is divesting its Life Sciences and Healthcare business segment to Altaris, LLC

The transaction includes customary representations, warranties, and covenants between parties

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJul 6, 2026
Item2.01
CategoryAcquisition/Disposition
CIK0001764046
Accession #clvt-20260706
Risk LevelMEDIUM
SentimentNeutral
Signalopportunity
Topics
divestiturerestructuring

What This Means

The company completed a major acquisition or sold off a significant asset. This reshapes the company's portfolio and strategic direction.
View Full Filing on SEC.govBrowse More Filings